ISPC
iSpecimen Inc.
NASDAQ · Healthcare · Medical - Diagnostics & Research · US
$0.84
+6.75%Price chart
Oct 6Oct 9Oct 14Oct 19Oct 22Oct 27Oct 30Nov 4
Key dataNov 4, 2026
Open$0.83
From 52W high−96.87%
Volume165374.00
Market cap$2.12M
P/E (TTM)—
P/S (TTM)4.6x
Div yield—
Key dataNov 4, 2026
Open
$0.83
From 52W high
−96.87%
Volume
165374.00
Market cap
$2.12M
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
0.2x
P/E (TTM)
—
RSI (14)
35.6
MomentumView details →
1D Return
+6.75%
YTD Return
−91.92%
SummaryUpdated Jun 1, 2026
iSpecimen Inc. (NASDAQ:ISPC) is a biotechnology services company founded in 2009 and headquartered in Lexington, Massachusetts. The company went public in June 2021 through an initial public offering. iSpecimen operates as a technology-enabled marketplace that connects life science researchers with healthcare organizations that have access to human biological specimens needed for medical research and drug development.
Similar companies
Latest newsMore news →
iSpecimen Inc. announced expanded access to prospectively collected, fully consented healthy donor whole blood through an existing collection partner.6d agoiSpecimen is supporting a hospital laboratory's validation of a new chemistry analyzer by coordinating the collection of more than 1,700 human specimens.36d ago